Teva UK Latest News Feed

Teva triumphs in Europe

2008-12-16 14:43:24

Teva UK Limited is celebrating success on a European platform, after a team from its Primary Care business secured second place at the highly competitive IMS Business Simulation European Finals.

The team, which comprised Sales Representatives Charlotte Crook and Mark Lee, Healthcare Development Manager, Jon Kerr, and Regional Sales Manager, Christian Griffin, came a very close second, finishing just 1% behind the ultimate winners in what was a very close-run competition.

John Beighton, Managing Director of Teva UK Limited, said: “I’m tremendously proud of the team and the success they’ve achieved in this competition. It’s a real endorsement of the drive and dedication that Teva expects from all its salesforces that the team has done so well.”

The IMS Business Simulation European Finals form part of the IMS Local Sales Championships. Launched in 2006, this competition takes place in a variety of European countries, and the winners from each country are invited to compete against each other on in a computer-based business simulation where the winner takes all.

Charlotte Crook was named winner of the IMS Business Simulation Award at the Pf Awards earlier this year.

Teva wins Generic Manufacturer of the Year accolade

2008-11-11 17:38:28

Teva UK Limited has again been named the UK’s Generic Manufacturer of the Year at a pharmacy awards ceremony.

The awards, which are organised by Pharmacy Business magazine, recognise and reward the hard work done by pharmacists. They also honour the manufacturers and products that have stood out throughout the year – either through exceptional service, or through customer demand. Most importantly, they are voted for by pharmacists across the country, who read Pharmacy Business magazine.

This is the sixth consecutive year that Teva has been recognised as the best generics company in the UK. Kim Innes, Commercial Director, Teva UK Limited, commented: “Winning this award is a real endorsement for Teva Generics – particularly because it is voted for by our customers.”

For more information on how Teva and generic medicines can help your pharmacy, call the helpline free on 0800 085 8621.

Teva steps up UK investment programme

2008-07-25 10:49:57

Teva UK Limited, the UK’s leading generics manufacturer, has taken a major step forward in its UK investment programme with the burial of a time capsule at the site of its new head office and logistics centre.

The ceremony, which was presided over by local Castleford MP and Chief Secretary to the Treasury, Yvette Cooper, marked a milestone in the company’s investment programme. Earlier this year, Teva announced plans to relocate its head office and logistics centre to a brand new, purpose built site near Castleford, West Yorkshire. The new building has a capacity no less than five times bigger than the current site, or floor space covering the equivalent of three football pitches.

The facility will be the company’s main UK distribution hub, significantly expanding and strengthening its supply chain warehouse and logistics activity. The highly automated, state-of-the-art systems will bring benefits in terms of both supply and service. The company says that the move is on track, and the new site should be fully operational during the first part of 2009.

It all comes as part of Teva’s increased investment in the UK. Last year, it created a respiratory and regulatory Centre of Excellence in Harlow, and is also planning other investments in the UK.

John Beighton, Teva’s Managing Director in the UK, said: “The move is a really big project for us – one that helps consolidate our position as one of the UK’s leading pharmaceutical companies. But more importantly, the new site will bring big improvements for our customers, as we finally have the space and the facilities to provide the best possible service.”

Teva creates piece of history

2008-06-16 14:07:17

A piece of history will be created next month when local MP and Chief Secretary to the Treasury, Yvette Cooper, will attend a ceremony at the site of the new Teva UK Limited head office and logistics centre to celebrate the burial of a time capsule.

The capsule will be filled with a series of mementoes that have been carefully chosen to represent the rich cultural heritage of its Yorkshire home, as well as the history of Teva.

Earlier this year, Teva announced plans to expand and strengthen its supply chain warehouse and logistic centre, and at the same time relocate its UK head office to the new purpose-built premises. The move will put Teva’s main logistics centre and head office staff in a brand-new building that has a capacity five times bigger than the firm’s existing site near Leeds, and will have enough floor space to cover three Old Trafford football pitches!

Teva says the project is developing apace and the new site will be equipped with fully-automated, state-of-the-art racking, picking and packing systems. These will help deliver great advances in terms of capacity, customer service and delivery of its medicines. The new site is expected to be fully operational later this year.

“This is a really exciting time at Teva,” said Managing Director John Beighton. “The move to the new site helps consolidate our position as one of the UK’s leading pharmaceutical companies. But more importantly, the new site will bring big improvements for our customers, as we finally have the space and the facilities to provide the best possible service. Equally important is our responsibility to the local area that we will soon be part of. The time capsule burial project is just one of a range of initiatives in our community relations programme.”

The time capsule, which has been put together with help from local schoolchildren, a local heritage group and Teva staff, will be buried at 12:45pm on Friday 11 July.

Teva welcomes election of Kim Innes as BGMA Chairman

2008-05-20 09:20:45

Teva has welcomed the election of Kim Innes, Director of the company’s generics business, as Chairman of the British Generic Manufacturers Association (BGMA) for a two-year term. During her spell in office, she will divide her time between Association duties and her role as Director, Teva Generics. John Beighton, Managing Director of Teva UK Limited, said he was delighted on both a personal and company level at Kim’s election: “Kim is an outstanding personality in the generics world and I’m delighted that she has been elected to lead our industry. Her vision, energy and knowledge of the industry will stand her in good stead, and I’m confident she will be an effective and vocal ambassador for the Association’s members on behalf of the generics industry and its customers.”

Kim has worked in the generics industry since 1991 and was appointed to head Teva’s generics business unit in the UK in 2006. John said: “We have a very strong management team in our generics business supporting Kim in her Teva Generics role, so she can devote some time to building on the BGMA’s already excellent work in supporting the industry’s call for a fair deal for generics. Meanwhile I look forward, as a member company of the BGMA, to working with Kim on telling the great story that the BGMA and its members have to offer.”

Teva UK Limited launches Student Bursary Scheme

2008-05-12 15:46:13

In a bid to help alleviate the current "demographic timebomb” facing pharmacy in the UK, Teva UK Limited, the UK’s leading generics manufacturer, is launching a Student Bursary Scheme.

The company is a keen supporter of pharmacy in the UK, and already has several initiatives in place to help pharmacists make the most of their role in the ever-changing UK healthcare climate. And now it’s extending this support to include the pharmacists of the future. The Student Bursary will be available to students who want to gain a degree-level qualification in pharmacy or similar but may suffer hardship without additional financial support.

Teva’s UK HR Director, Lynda Wilebore, said: “We’re delighted to be able to introduce the Student Bursary Scheme, which we hope will make an important contribution to lives of under-privileged students in the UK.”

She added: “We believe it is important to have a community support programme that is relevant to our business. As the UK’s leading generics company, we’re totally committed to pharmacy in the UK. This means we’re not only interested in supporting the pharmacists of today, but also in ensuring the pharmacists of tomorrow get the best possible start.”

The Student Bursary Scheme is open to any home UK student who is either already attending, or who has been offered a place on, any full-time UK-based undergraduate course approved by a school of pharmacy or similar. Each year, bursaries will be offered to students who may suffer difficulty without additional financial support. The company especially welcomes applications from A-level students who receive the Education Maintenance Allowance or Carers Allowance. Up to ten bursaries will be awarded each year, comprising £500 payment for each year of study. The closing date for the next round of applications is 1 September 2008.

For further information, including an information pack, how to apply and selection criteria, please contact the HR department – email careers@tevauk.com or telephone 08705 020304. Alternatively, visit www.tevauk.com/careers/bursary.

The closing date for the next round applications is 1 September 2008.

Teva welcomes Pharmacy White Paper

2008-04-03 17:46:30

Teva UK Limited, the biggest generic drug manufacturer in the UK, has welcomed news that this week’s Department of Health’s Pharmacy White Paper has opened the way for an expanded role for England’s pharmacies.

The paper envisages a number of changes for pharmacy, and the company says that it is pleased that health ministers have recognised the potential for community pharmacy to do more to address access to health and wellbeing services. “Medicines Use Reviews have already shown that community pharmacy, with the support of industry partners, can make a real difference to patients’ lives,” said Teva’s Managing Director John Beighton. “They also show that pharmacy has the capability and resolve to do more under the Contract. The White Paper can move this forward and position pharmacy as an essential component of delivering healthcare in the community.”

Mr Beighton called on contractors to make the most of the sources of help they already have to be in the best position to capitalise on new opportunities. “Firms like Teva are already offering help to deliver MURs and other services. My message is to say that people like us are available to help – take that help from partners, build relationships with industry that enable contractors to be ready for the first day of every new service.”

Mr Beighton added that the company’s Partners in Progress programme, launched in late 2007 to help contractors deliver MURs, was an example of how pharmacy and industry partners could work together to provide a sustainable programme that delivers patient care and benefits to pharmacy.

Link to White Paper

Pharmacy in England: building on strengths - delivering the future published by The Stationery Office on 3 April 2008 and available at http://www.official-documents.gov.uk/document/cm73/7341/7341.pdf

Teva UK Limited launches new website

2008-02-18 12:38:37

Teva UK Limited has launched a new website.

The new website, which is at www.tevauk.com, has been fully updated with a fresh new approach and contemporary design. Teva believes the new site will provide comprehensive information about the company to its customers, partners and employees alike.

John Beighton, Managing Director of Teva UK Limited, said: “The new website is a major step forward for Teva and is part of our ongoing drive to provide the best possible communication with our customers and other key stakeholders. We feel that the site showcases the strength of our business as a market leader. The graphic design is designed to help to communicate our core business values and the site is easy to navigate.”

The new site includes:
• Clear design and navigation for users
• Detailed information about the company business and products
• Adverse drug reaction reporting facility
• Up-to-date news section, including fully searchable archive
• Interactive poll enabling visitors to vote on current “hot topics” in healthcare
• For the first time, the Teva UK Limited website also has a careers section, giving people the opportunity to become a part of the company’s future

The company hopes the website will be developed over time to include a comprehensive learning resource for its customers.

The launch is also being supported by a comprehensive advertising campaign.

New era for Teva in UK as plans announced for major expansion

2008-01-15 15:31:51

Teva UK Limited has announced plans to expand and strengthen its supply chain warehouse and logistic centre, and at the same time relocate its UK head office to new premises.
The company is planning to move its head office to Glasshoughton in West Yorkshire, at the junction of the M62 and A1 trunk roads, by the end of next year. The move will put the company’s main logistics centre, as well as over 150 head office staff, in a brand-new expanded site that has a capacity no less than five times bigger than the firm’s existing site near Leeds.

“This is a very exciting time at Teva UK Limited,” said Managing Director John Beighton. “With the new respiratory, regulatory and Teva Europe Centre of Excellence at Harlow, plus investment in our plant at Eastbourne, we are consolidating our position as one of the UK’s leading pharmaceutical companies. But more importantly, the new site will bring big improvements for our customers, as we finally have the space and the facilities to provide the best possible service.”

The new site is about to start construction and will be equipped with the most modern equipment for storage and for picking of orders – an important consideration given that the company currently markets over 500 product lines and is believed to be the biggest single supplier of boxes of medicines to the NHS.

Sandra Gidley MP visits Teva

2007-09-04 07:12:54

Sandra Gidley MP has paid a visit to a UK pharmaceutical industry packaging centre.

Ms Gidley, who is Liberal Democrat MP for Romsey and also a Liberal Democrat Shadow Health spokesperson, donned protective gear to find out exactly how the Teva UK Limited site in Eastbourne, East Sussex, packages 2.9 million boxes of tablets every week of the year.

It is important to understand the contribution the generics industry makes to the UK healthcare economy, commented Ms Gidley. Today's tour of the Teva facilities has given me a valuable insight into the workings behind the UK's leading generics manufacturer.

Said Kim Innes, Director Teva Generics and Chairman elect of British Generic Manufacturers' Association: As the biggest supplier of boxes of medicines to the NHS, we have a responsibility in keeping those that make healthcare policy in touch with our industry.

Ms Gidley's visit took in the site's entire packaging and distribution facilities, giving her a rare journey behind the scenes of one of the UK's leading pharmaceutical companies. With a portfolio in excess of 500 products, Teva supplies the UK's National Health Service with more boxes of medicine than any other company. It produces 8 billion tablets and capsules every year equivalent to approximately one in every five tablets taken in the UK.

Teva drives its brand forward

2007-06-28 05:00:27

Teva's generics packaging has been put on the companys biggest box yet, with a new fleet of Teva-liveried lorries set to become a familiar sight on Britains roads.

The iconic lorries, which feature colourful Teva ‘circles’ as introduced on the company’s packaging, are used to distribute the company’s products between the company’s sites and to wholesaler customers. The livery, which has already received several accolades in the pharmaceutical field and in graphic design, has adapted well to the biggest ‘pack’ ever to carry the Teva name.

Karl Belk, Teva’s Operations Director, said: “We’re a growing company with a growing brand, and this is just one example of how we are putting this into practice.”